New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market (2025-2031) | Competitive Landscape, Outlook, Trends, Share, Growth, Segmentation, Value, Industry, Forecast, Size & Revenue, Analysis, Companies

Market Forecast By Cancer Type (Lung, Breast, Colorectal, Prostrate, Stomach, Cervical, Leukemia, Others), By Product and Service (Kits, Software and Services, Instruments), By Technologies (Panels/Targeted Sequencing and Resequencing, Whole Exome Sequencing, Whole Genome Sequencing, RNA Sequencing, Other Sequencing Technologies), By Workflow (NGS Sequencing, NGS Data Analysis, NGS Pre-Sequencing), By Application (Screening, Companion Diagnostics, Others), By End User (Pathology Labs, Hospitals, Oncology Centers, Others), By Distribution Channel (Direct Tender, Retail Sales) And Competitive Landscape
Product Code: ETC8565516 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Outlook
  • Market Size of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, 2024
  • Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Revenues & Volume for the Period 2021- 2031
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Trend Evolution
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Drivers and Challenges
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Price Trends
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Porter's Five Forces
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Industry Life Cycle
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Lung for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Breast for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Colorectal for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Prostrate for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Stomach for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Cervical for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Leukemia for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Lung Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Product and Service for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Kits for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Software and Services for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Instruments for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Technologies for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Panels/Targeted Sequencing and Resequencing for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Whole Exome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Whole Genome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By RNA Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Other Sequencing Technologies for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Workflow for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By NGS Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By NGS Data Analysis for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By NGS Pre-Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Screening for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Companion Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Pathology Labs for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Oncology Centers for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Direct Tender for the Period 2021- 2031
  • Historical Data and Forecast of New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume By Retail Sales for the Period 2021- 2031
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Import Export Trade Statistics
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By Product and Service
  • Market Opportunity Assessment By Technologies
  • Market Opportunity Assessment By Workflow
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End User
  • Market Opportunity Assessment By Distribution Channel
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Top Companies Market Share
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Competitive Benchmarking By Technical and Operational Parameters
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Company Profiles
  • New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Overview

3.1 New Zealand Country Macro Economic Indicators

3.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, 2021 & 2031F

3.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Industry Life Cycle

3.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Porter's Five Forces

3.5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.6 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Product and Service, 2021 & 2031F

3.7 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Technologies, 2021 & 2031F

3.8 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F

3.10 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F

3.11 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Trends

6 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Types

6.1 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Cancer Type

6.1.1 Overview and Analysis

6.1.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Cancer Type, 2021- 2031F

6.1.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Lung, 2021- 2031F

6.1.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Breast, 2021- 2031F

6.1.5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Colorectal, 2021- 2031F

6.1.6 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Prostrate, 2021- 2031F

6.1.7 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Stomach, 2021- 2031F

6.1.8 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Cervical, 2021- 2031F

6.1.9 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Product and Service

6.2.1 Overview and Analysis

6.2.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Kits, 2021- 2031F

6.2.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Software and Services, 2021- 2031F

6.2.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F

6.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Technologies

6.3.1 Overview and Analysis

6.3.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Panels/Targeted Sequencing and Resequencing, 2021- 2031F

6.3.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.3.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.3.5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By RNA Sequencing, 2021- 2031F

6.3.6 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F

6.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By NGS Sequencing, 2021- 2031F

6.4.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.4.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By NGS Pre-Sequencing, 2021- 2031F

6.5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Application

6.5.1 Overview and Analysis

6.5.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Screening, 2021- 2031F

6.5.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.5.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.6 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By End User

6.6.1 Overview and Analysis

6.6.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Pathology Labs, 2021- 2031F

6.6.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F

6.6.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Oncology Centers, 2021- 2031F

6.6.5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

6.7 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Distribution Channel

6.7.1 Overview and Analysis

6.7.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Direct Tender, 2021- 2031F

6.7.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenues & Volume, By Retail Sales, 2021- 2031F

7 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Import-Export Trade Statistics

7.1 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Export to Major Countries

7.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Imports from Major Countries

8 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Key Performance Indicators

9 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Opportunity Assessment

9.1 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Product and Service, 2021 & 2031F

9.3 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Technologies, 2021 & 2031F

9.4 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F

9.6 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F

9.7 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market - Competitive Landscape

10.1 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Revenue Share, By Companies, 2024

10.2 New Zealand Next Generation Sequencing (NGS) in Cancer Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All